首页> 外文期刊>Journal of otolaryngology - head & neck surgery = >Endoscopic intratympanic methylprednisolone injection for treatment of refractory sudden sensorineural hearing loss and one case in pregnancy.
【24h】

Endoscopic intratympanic methylprednisolone injection for treatment of refractory sudden sensorineural hearing loss and one case in pregnancy.

机译:内镜下鼓室注射甲基强的松龙治疗难治性突然的感音神经性听力损失和1例妊娠。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: to evaluate the effectiveness of transtympanic methylprednisolone injection in patients with refractory sudden sensorineural hearing loss via endoscopic diode laser myringotomy. SUBJECTS AND METHODS: thirty-six sudden sensorineural hearing loss patients who failed routine oral steroid therapy and two patients with a contraindication to systemic steroid received intratympanic methylprednisolone injections at the round window by endoscopic diode laser myringotomy once every other day with a maximum of four injections. One of the two patients with a contraindication to oral steroid was a normal pregnant woman, whereas the other was an active digestive ulcer patient. Hearing level, dizziness, and tinnitus were evaluated before the first procedure and 20 days after the last injection. RESULTS: thirteen of 38 patients (34.2%) showed an improvement in hearing levels. The average improvement 20 days after treatment was 54 dB in the hearing thresholds of 125 to 8000 Hz. The complete recovery rate of intratympanic methylprednisolone injection (mean 2.6 times) was 21% (8 of 38). There were no serious unexpected adverse events in the 38 patients except one aggravation of hearing loss occurred after intratympanic injection. Temporary dizziness in seven subjects and otalgia in six subjects occurred after injection, which was relieved after 0.5 to 2 hours without special treatment. No perforation of tympanic membrane or infection occurred 20 days after the last injection. CONCLUSIONS: topical intratympanic injection may be considered a substitute for the systemic administration in patients with refractory sudden hearing loss, especially those who have contraindications to systemic steroid administration. The endoscope is helpful for ensuring the effective delivery of drugs into the round window. Prospective randomized controlled trials should be designed for further investigation.
机译:目的:通过内镜下二极管激光肾切开术,评估经鼓室注射甲基强的松龙对难治性突然感觉神经性听力损失的疗效。研究对象和方法:常规口服类固醇治疗失败的36例突然的感音神经性听力减退患者和2例全身性类固醇禁忌症患者每隔一天通过内窥镜二极管激光晶状体切开术在圆窗处注射鼓膜内甲基强的松龙,最多可进行四次注射。口服类固醇禁忌症的两名患者中,一名是正常孕妇,另一名是活动性消化性溃疡患者。在第一次手术前和最后一次注射后20天评估听力水平,头晕和耳鸣。结果:38名患者中有13名(34.2%)的听力水平有所改善。在治疗后20天,听力阈值为125至8000 Hz,平均改善为54 dB。鼓室内注射甲基强的松龙的完全恢复率(平均2.6倍)为21%(38个中的8个)。 38例患者中没有严重的意外不良事件,但鼓膜内注射后有1例听力丧失加重。注射后发生了七名受试者的暂时头晕和六名受试者的耳痛,这些症状在0.5至2小时后得到缓解,无需特殊治疗。最后一次注射后20天未发生鼓膜穿孔或感染。结论:对于难治性突然听力下降的患者,尤其是全身性激素治疗禁忌症的患者,局部鼓膜内注射可被认为是全身性给药的替代品。内窥镜有助于确保药物有效地输送到圆形窗口中。应设计前瞻性随机对照试验以供进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号